Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M. Brett‐Major, Paul T. Scott, Jason F. Okulicz et al.|Hepatology|2015Cited by 10
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T. Scott, Sheila A. Peel, Robert Cohen et al.|Military Medicine|2020Cited by 3